Group 1 - The core viewpoint of the article highlights the significant increase in the stock price of iFlytek Medical Technology, which rose by 4.19% to HKD 78.35, with a trading volume of HKD 7.8092 million [1] - iFlytek Medical announced that eight shareholders, including iFlytek and Kexin Venture Capital, have committed not to reduce their holdings of H-shares or unlisted shares until December 29, 2026. These shareholders collectively hold 55.7584 million H-shares, representing 68.25% of the total H-share capital, and 88.0682 million shares, accounting for 72.86% of the total share capital [1] - The company has signed a strategic cooperation agreement with the Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, marking an important milestone in its expansion in the smart medical field and providing a new opportunity for the hospital to achieve technological upgrades [1]
港股异动 | 讯飞医疗科技(02506)再涨超4% 8名股东自愿延长禁售 智慧医疗领域持续拓展